Psychedelic therapy trial for terminally ill patients shows improved quality of life

A small, Australia-first psychedelic-assisted therapy trial shows rapid and sustained reductions in depression and anxiety, while improving overall quality of life for patients diagnosed with a terminal illness.

Published: 1 September 2025

Thirty-five participants were studied in the trial, which took more than three years.

Researchers say more work needs to be done to deliver this type of therapy more broadly.